Clinical characteristics and cytokine profiles for early prediction of severe Mycoplasma pneumoniae pneumonia in children: a prospective cohort study - Report - MDSpire
Advertisement
Clinical characteristics and cytokine profiles for early prediction of severe Mycoplasma pneumoniae pneumonia in children: a prospective cohort study
Clinical Report: Early Identification of Severe Mycoplasma pneumoniae Pneumonia
Overview
This study investigates the clinical features and cytokine profiles of children with Mycoplasma pneumoniae pneumonia (MPP) to establish a predictive nomogram for early identification of severe cases.
Background
Mycoplasma pneumoniae is a significant cause of community-acquired pneumonia in children, particularly affecting those under six years of age. Identifying children at risk for severe disease early is critical for timely intervention and improved outcomes. This study addresses the challenge of recognizing severe cases during the early stages of MPP.
Data Highlights
Parameter
Odds Ratio (OR)
95% Confidence Interval (CI)
Wheezing
4.016
1.609–10.029
Shortness of breath
4.717
1.290–16.008
D-dimer
3.032
1.926–4.773
CRP
1.033
1.018–1.048
Fever
3.432
1.658–7.105
Age
1.114
1.015–1.223
Key Findings
57.3% of children with MPP developed severe Mycoplasma pneumoniae pneumonia (SMPP).
Independent risk factors for SMPP include wheezing, shortness of breath, fever, D-dimer, CRP, and age.
The predictive nomogram achieved an AUC of 0.818, indicating good discrimination ability.
Serum cytokines such as HMGB-1, TFEB, and TNF-α were significantly elevated in the SMPP group compared to the mild MPP group.
Dynamic monitoring of cytokines may aid in understanding disease progression in MPP.
Clinical Implications
Healthcare professionals should consider the identified clinical features and laboratory parameters when assessing children for the risk of severe Mycoplasma pneumoniae pneumonia.
Conclusion
The study provides a predictive nomogram for early risk stratification of SMPP in children.
